Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

50.0%

1 terminated/withdrawn out of 2 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2)

Showing 2 of 2 trials
NCT05800704Not ApplicableActive Not Recruiting

Support of Colonization Resistance of the Gut Microbiota with the Synbiotic Food Supplement Nagasin®

Role: collaborator

NCT05986773Phase 4Terminated

Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance

Role: lead

All 2 trials loaded